Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02846623
Brief Title: Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome

First Submitted : July 22, 2016
First Submitted that Met QC Criteria : July 22, 2016
First Posted : July 27, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 15, 2019
Last Update Posted : August 19, 2019